May 2, 2024

Assess Your Antibodies from Every Angle: The Importance of Orthogonal Assays in Monoclonal Antibody Activity Characterization

mAbs are vital biopharmaceutical tools with potential uses in oncology and autoimmune diseases. To ensure their efficacy and safety, it's essential to have a deep understanding of their functional attributes.

Asses your antibodies from every angle with iLite® Technology. Experience an orthogonal approach to antibody evaluation tailored to your needs.

Our range of assay-ready reporter cell lines delivers comprehensive insights into antibody functionality. From binding affinity to immune effector functions like Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Antibody-Dependent Cellular Phagocytosis (ADCP), and Complement-Dependent Cytotoxicity (CDC)

iLite® Empowers You to Understand Your Antibodies Like Never Before. Discover the Difference for Your Research Today!

May 2, 2024

Assess Your Antibodies from Every Angle: The Importance of Orthogonal Assays in Monoclonal Antibody Activity Characterization

mAbs are vital biopharmaceutical tools with potential uses in oncology and autoimmune diseases. To ensure their efficacy and safety, it's essential to have a deep understanding of their functional attributes.

Asses your antibodies from every angle with iLite® Technology. Experience an orthogonal approach to antibody evaluation tailored to your needs.

Our range of assay-ready reporter cell lines delivers comprehensive insights into antibody functionality. From binding affinity to immune effector functions like Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Antibody-Dependent Cellular Phagocytosis (ADCP), and Complement-Dependent Cytotoxicity (CDC)

iLite® Empowers You to Understand Your Antibodies Like Never Before. Discover the Difference for Your Research Today!

Streamline Your Comprehensive Antibody Assessment 

The activities of monoclonal antibodies (mAB) are diverse as they involve interactions with immune effector cells and complement components. Understanding the intricate functionality of mAB is pivotal for unlocking their true efficacy and mechanism of action.

Enter the world of iLite ADCP, ADCC, and CDC assays, where each facet of mAB behavior is meticulously illuminated, offering you an unparalleled depth of insight into their functionality with one powerful technology!

 

NEW SCIENTIFIC POSTER: The Best-In-Class Bioassays

Download this NEW scientific poster and see how  iLite® ADCC and ADCP assays significantly outperform competitors, showcasing superior sensitivity and dynamic range. Our CDC assay, using a unique Svar luciferase-expressing cell line, ensures fast, robust, and reproducible results, customizable to any cell surface antigen.

Get your free copy

Antibody-Engineering London May 2024 (1)

 

Drive Informed Decision-Making

Through strategic integration of CDC, ADCC, and ADCP assays, you can navigate the complex landscape of mAb therapeutics with confidence and precision.

Unlock the insights you need to assess your antibodies from every angle and embark on a journey of transformative mAb development!

Seeking Tailored Solutions?

We can tailor the iLite CDC, ADCC and ADCP bioassays,  to the unique needs of your antibody characterization project.

Tap into our cell engineering expertise – reach out today to discuss your target antigen and gain a competitive edge in your research journey!

3-2

Want to learn about assessing ADCC and ADCP?

Download this white paper and discover how iLite® assays provide a robust and user-friendly approach to measuring ADCC and ADCP activity.

Get your free copy

Ready to Dive In?

Explore our range of effector and target cell portfolio for ADCC and ADCP assays. Order your ADCC and ADCP assays now and embark on a journey of discovery.

Looking to Know More about How to Optimal Assess CDC?

Download this white paper and uncover the secrets of designing optimal bioassays for measuring CDC activity. See how iLite® assays offer a powerful and convenient solution for assessing CDC activity with clever cell engineering to truly reflect cell lysis.

Get your free copy

Ready to Dive In?

Explore our range of target cell portfolio for CDC bioassays. Order your CDC assays now and embark on a journey of discovery.

2-3

Experience the next level of precision

By eliminating the variability and labor-intensive processes of traditional assays, our innovative solutions accelerate therapeutic antibody characterization and streamline the drug development pipeline.

Experience the next level of precision in therapeutic antibody evaluation with our cutting-edge iLite® technology.

Your Antibody is Unique, so are Our Solutions!

We can tailor the iLite CDC, ADCC and ADCP bioassays,  to the unique needs of your antibody characterization project.

Tap into our cell engineering expertise – reach out today to discuss your target antigen and gain a competitive edge in your research journey!